<DOC>
	<DOCNO>NCT01536236</DOCNO>
	<brief_summary>To obtain preliminary estimate safety efficacy ANS Eonâ„¢ Implantable Pulse Generator ANS lead treatment subject diabetic polyneuropathy .</brief_summary>
	<brief_title>Spinal Cord Stimulation Diabetic Polyneuropathy</brief_title>
	<detailed_description>There medication arm stimulation arm . Patients randomize one . If patient randomize medication arm , 6 month option go stimulation arm . There 3 week trial include crossover period `` stimulation '' subthreshold stimulation . The 3rd week patient receive `` optimal '' stimulation . If qualify , implanted permanent device .</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>1 . The subject 18 year age old 2 . The subject sign receive copy inform consent form nature study fully explain . 3 . The subject clinical diagnosis diabetes mellitus 4 . The subject A1C le equal 10 % within last 3 month . 5 . The subject stable diabetic therapy least 3 month without hospitalization control diabetes . 6 . The subject document clinical diagnosis painful diabetic distal symmetric sensory/motor polyneuropathy use LANSS ( Leeds assessment neuropathic symptom sign ) pain scale score 12 great TNS ( total neuropathy score ) score 20 great . 7 . The subject bilateral , moderate severe pain diabetic polyneuropathy previous 3 month . 8 . The subject VAS &gt; 4 Baseline , stable analgesic regimen consist one combination follow agent : anticonvulsant , antidepressant , opioids 1 month . 9 . The subject show refractory conservative therapy fail minimum 3 conservative treatment least one medication specifically diabetic polyneuropathy adequate dose duration 10 . Female subject negative pregnancy test . 1 . Subject unwilling unable , opinion investigator , comply study instruction . 2 . Subject severe pain could confound assessment pain due diabetic polyneuropathy . 3 . Subject neuropathy investigator considers due diabetes ( e.g. , significant vasculitis , collagen vascular disorder , medication know cause neuropathy , history familial neuropathy , drug alcohol abuse , hepatitis , HIV , infection pernicious anemia ) 4 . Subject amputation . 5 . Subject diagnosis within past 1 year major psychiatric disturbance . Exclusionary psychiatric diagnosis include follow Axis I disorder ( DSMIVR criterion ) : major depression , bipolar disorder , schizophrenia psychotic disorder somatoform disorder . The Axis II disorder borderline personality also exclude . 6 . Subject coexistent , major systemic disease ( ) would interfere interpretation study result ( e.g . malignancy , poorly control diabetes , ischemic cardiac disease , profound autonomic dysfunction disease opinion investigator . ) 7 . Subject abnormal PT , PTT , bleed time platelet count might interfere therapy . 8 . Subject currently participate , within past 30 day , participate study another investigational drug device . 9 . Subject history substance abuse within past 2 year . 10 . Subject demandtype pacemaker implant cardiac defibrillator . 11 . Subject require diathermy MRIs . 12 . Subject metallic implant might interfere therapy opinion investigator ; 13 . Subject implanted medication pump implant neurostimulation device . 14 . Subject currently active infection . 15 . Subject currently foot ulcer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Polyneuropathy</keyword>
	<keyword>Spinal cord stimulation</keyword>
</DOC>